In this context, we have shown that the hepatic overexpression of the transcription active domain of SREBP-1c increases hepatic DNL, without severe insulin resistance, resulting in a fatty liver and a massively increased adipose tissue mass in mouse models [7,8]. This evidence concerns the gene SREBF1 and Insulin resistance.